한글목차

세계의 펨테크 시장 규모는 2024년에 393억 4,000만 달러로 평가되었고 예측 기간 중 CAGR은 16.41%를 나타낼 전망이며, 2030년에는 978억 8,000만 달러에 달할 것으로 예상됩니다.

세계의 펨테크 시장은 디지털 리터러시율의 상승, 인터넷 접속, 스마트폰의 보급, 디지털 헬스케어 인프라에 의해 큰 성장을 이루고 있습니다. 게다가 피트니스 트래커와 스마트 워치와 같은 스마트 웨어러블 디바이스의 보급이 펨테크 시장의 성장을 밀어올릴 것으로 예측됩니다. 또한 선진국 및 신흥 국가에서 디지털 솔루션의 도입이 증가하고 기술이 발전함에 따라 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 펨테크은 여성의 건강과 행복을 향상시키는 기술입니다. 이 용어는 시스젠더 여성, 성별 또는 성별 마이너리티 여성을 포함하되 이에 국한되지 않는 여성의 건강을 증진 또는 지원하기 위한 프로그램, 서비스, 제품, 소프트웨어, 하드웨어, 비타민제, 보충제, 원격 의료, 웨어러블, 디지털 플랫폼, 소비재를 가리키는 데 자주 사용됩니다.

펨테크 기업은 여성 특유의 헬스케어와 웰니스 요구에 부응하는 기술 제품 및 서비스의 개발에 주력하고 있습니다. 여성의 건강과 복지의 중요성에 대한 의식이 높아짐에 따라 펨테크 제품에 대한 수요도 높아지고 있습니다. 게다가 큰 수익을 기대할 수 있기 때문에 펨테크 기업에 대한 투자에 대한 투자자의 관심도 높아지고 있습니다. 예를 들어 PitchBook에 따르면 2020년 펨테크 기업은 8억 2,000만 달러 이상의 자금을 조달했습니다. 따라서 이 시장에서의 투자 기회 증가는 펨테크 시장의 성장을 지원할 것으로 예측됩니다.

주요 시장 성장 촉진요인

여성 건강 문제 유병률 상승

주요 시장 과제

의료 연구 및 설계의 성별 바이어스

주요 시장 동향

불임·생식 의료 솔루션 확대

목차

제1장 개요

• 시장의 정의
• 시장 범위
  • 대상 시장
  • 조사 대상 연도
  • 주요 시장 세분화

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 펨테크 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율·예측
  • 제품별(모바일 앱, 커넥티드 디바이스, 서비스, 기타)
  • 용도별(생식 건강, 일반 건강, 임신 및 간호, 골반 및 자궁 관리)
  • 최종 용도별(개인, 불임 치료 클리닉, 병원, 연구 기관, 진단센터)
  • 지역별
  • 기업별(2024년)
• 제품 맵
  • 제품별
  • 용도별
  • 최종 용도별
  • 지역별

제6장 유럽의 펨테크 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 프랑스
  • 영국
  • 이탈리아
  • 독일
  • 스페인

제7장 북미의 펨테크 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제8장 아시아태평양의 펨테크 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 펨테크 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 펨테크 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 아랍에미리트(UAE)
  • 사우디아라비아

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 제품 출시
• 합병과 인수
• 기술적 진보

제13장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협/서비스

제14장 세계의 펨테크 시장 : SWOT 분석

제15장 경쟁 구도

• ALYK, Inc.
• Aytu BioScience, Inc.
• Biowink GmbH
• Flo Health, Inc.
• Glow, Inc.
• NaturalCycles Nordic AB
• Ovia Health
• Plackal Tech
• The Flex Company
• Thinx, Inc.

제16장 전략적 제안

제17장 기업 소개와 면책사항

영문목차

Global Female Technology (Femtech) Market was valued at USD 39.34 Billion in 2024 and is expected to reach USD 97.88 Billion by 2030 with a CAGR of 16.41% during the forecast period. The global market for Female Technology (Femtech) is experiencing significant growth, driven by the increasing digital literacy rates, internet connectivity, smartphone penetration, and digital healthcare infrastructure. Further, the growing availability of smart wearable devices such as fitness trackers, and smartwatches are anticipated to lift the growth of the Female Technology (Femtech) market. In addition, the increasing adoption of digital solutions in developed and developing countries combined with advancements in technologies is expected to fuel the growth of the market during the forecast period. FemTech (Female Technology) is a technology that improves the health and well-being of women. This term is frequently used to refer to programs, services, products, software, hardware, vitamins, supplements, telehealth, wearables, digital platforms, and consumer goods intended to enhance or support the health of women, including but not limited to those who identify as cisgender women and women from gender or sexual minorities.

Femtech companies are focused on developing technology products and services that cater to the unique healthcare and wellness needs of women. As awareness about the importance of women's health and well-being increases, so does the demand for Femtech products. Additionally, investors are increasingly interested in investing in Femtech companies due to the potential for significant returns. For instance, in 2020, Femtech companies received over $820 million in funding, according to PitchBook. Hence, rising investment opportunities in the market is anticipated to support the growth of the Female Technology (Femtech) market.

Key Market Drivers

Rising Prevalence of Women's Health Issues

The increasing incidence of women's health conditions is a major catalyst for the growth of the Femtech market. Conditions such as endometriosis, polycystic ovary syndrome (PCOS), and menopause-related complications are becoming more prevalent, necessitating specialized healthcare solutions. According to the World Health Organization (WHO), endometriosis affects approximately 190 million women globally, equating to about 10% of women of reproductive age. This growing burden has highlighted the inadequacies in traditional healthcare systems to address women's specific health needs effectively. Consequently, there is a surge in demand for Femtech solutions that offer personalized care, remote monitoring, and data-driven insights. These technologies empower women to manage their health proactively, leading to better outcomes and increased quality of life.

Governments and healthcare organizations are also recognizing the importance of addressing women's health issues. Initiatives aimed at increasing awareness, funding research, and integrating women's health into broader healthcare policies are gaining momentum. Such support not only validates the significance of Femtech but also provides a conducive environment for its growth and integration into mainstream healthcare.

Key Market Challenges

Gender Bias in Medical Research and Design

A significant challenge facing the Femtech industry is the persistent gender bias in medical research and product design. Historically, medical studies have predominantly focused on male subjects, leading to a lack of comprehensive understanding of female physiology and health conditions. This oversight results in the development of healthcare solutions that may not effectively address women's specific needs. In the context of Femtech, this bias manifests in products that are not adequately tested or tailored for women, potentially compromising their efficacy and safety. Furthermore, the underrepresentation of women in clinical trials and research studies perpetuates this cycle, hindering the advancement of evidence-based solutions in women's health.

Addressing this challenge requires a concerted effort to prioritize gender-inclusive research and development. This includes ensuring diverse representation in clinical studies, investing in research focused on women's health issues, and involving women in the design and testing of healthcare technologies. Governmental policies and funding initiatives that support such inclusive practices are essential to overcoming this barrier and fostering innovation in the Femtech sector.

Key Market Trends

Expansion of Fertility and Reproductive Health Solutions

The Femtech market is witnessing a significant trend towards the expansion of fertility and reproductive health solutions. With societal shifts leading to delayed childbearing and increased awareness of reproductive health, there is a growing demand for technologies that assist in fertility tracking, conception, and overall reproductive wellness. Innovations in this space include mobile applications that monitor ovulation cycles, wearable devices that track physiological indicators, and telemedicine platforms offering consultations with fertility specialists. These tools empower women with information and support, enabling informed decisions about their reproductive health.

Furthermore, the integration of artificial intelligence (AI) and machine learning into these solutions enhances their predictive capabilities, offering personalized recommendations and early detection of potential issues. This technological advancement not only improves user experience but also increases the efficacy of fertility treatments. Healthcare providers and policymakers are also recognizing the importance of reproductive health, leading to increased funding and supportive regulations. Such initiatives facilitate the development and accessibility of fertility-focused Femtech solutions, contributing to the overall growth of the market.

Key Market Players

• ALYK, Inc.
• Aytu BioScience, Inc.
• Biowink GmbH
• Flo Health, Inc.
• Glow, Inc.
• NaturalCycles Nordic AB
• Ovia Health
• Plackal Tech
• The Flex Company
• Thinx, Inc.

Report Scope:

In this report, the Global Female Technology (Femtech) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Female Technology (Femtech) Market, By Product:

• Mobile Apps
• Connected Devices
• Services
• Others

Female Technology (Femtech) Market, By Application:

• Reproductive Health
• General Wellness
• Pregnancy and Nursing Care
• Pelvic and Uterine Care

Female Technology (Femtech) Market, By End-use:

• Individuals
• Fertility Clinics
• Hospitals and Research Institutes
• Diagnostic Centers

Female Technology (Femtech) Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Female Technology (Femtech) Market.

Available Customizations:

Global Female Technology (Femtech) Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Female Technology (Femtech) Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
  • 5.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
  • 5.2.3. By End-use (Individuals, Fertility Clinics, Hospitals, and Research Institutes, Diagnostic Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Map
  • 5.3.1. By Product
  • 5.3.2. By Application
  • 5.3.3. By End-use
  • 5.3.4. By Region

6. Europe Female Technology (Femtech) Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
  • 6.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
  • 6.2.3. By End-use (Individuals, Fertility Clinics, Hospitals, and Research Institutes, Diagnostic Centers)
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Female Technology (Femtech) Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-use
  • 6.3.2. United Kingdom Female Technology (Femtech) Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-use
  • 6.3.3. Italy Female Technology (Femtech) Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-use
  • 6.3.4. Germany Female Technology (Femtech) Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End-use
  • 6.3.5. Spain Female Technology (Femtech) Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End-use

7. North America Female Technology (Femtech) Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
  • 7.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
  • 7.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Female Technology (Femtech) Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-use
  • 7.3.2. Mexico Female Technology (Femtech) Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-use
  • 7.3.3. Canada Female Technology (Femtech) Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-use

8. Asia-Pacific Female Technology (Femtech) Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
  • 8.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
  • 8.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Female Technology (Femtech) Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-use
  • 8.3.2. India Female Technology (Femtech) Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-use
  • 8.3.3. Japan Female Technology (Femtech) Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-use
  • 8.3.4. South Korea Female Technology (Femtech) Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-use
  • 8.3.5. Australia Female Technology (Femtech) Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-use

9. South America Female Technology (Femtech) Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
  • 9.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
  • 9.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Female Technology (Femtech) Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-use
  • 9.3.2. Argentina Female Technology (Femtech) Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-use
  • 9.3.3. Colombia Female Technology (Femtech) Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-use

10. Middle East and Africa Female Technology (Femtech) Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
  • 10.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
  • 10.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Female Technology (Femtech) Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-use
  • 10.3.2. UAE Female Technology (Femtech) Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-use
  • 10.3.3. Saudi Arabia Female Technology (Femtech) Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Product Launches
• 12.2. Mergers & Acquisitions
• 12.3. Technological Advancements

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Female Technology (Femtech) Market: SWOT Analysis

15. Competitive Landscape

• 15.1. ALYK, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Aytu BioScience, Inc.
• 15.3. Biowink GmbH
• 15.4. Flo Health, Inc.
• 15.5. Glow, Inc.
• 15.6. NaturalCycles Nordic AB
• 15.7. Ovia Health
• 15.8. Plackal Tech
• 15.9. The Flex Company
• 15.10. Thinx, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer